1. Fujiwara, Akira, Ozawa, Moe, Sumida, Koichiro, Wakui, Hiromichi, Tamura, Kouichi. . LPIN1 is a new target gene for essential hypertension. In Journal of hypertension, 40, 536-543. doi:10.1097/HJH.0000000000003046. https://pubmed.ncbi.nlm.nih.gov/34772856/
2. Park, Hee-Seon, Song, Ji-Won, Park, Jin-Ho, Won, Young-Suk, Kwon, Hyo-Jung. 2020. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. In Autophagy, 17, 2549-2564. doi:10.1080/15548627.2020.1834711. https://pubmed.ncbi.nlm.nih.gov/33190588/
3. Clifford, Bethan L, Sedgeman, Leslie R, Williams, Kevin J, Edwards, Peter A, de Aguiar Vallim, Thomas Q. 2021. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. In Cell metabolism, 33, 1671-1684.e4. doi:10.1016/j.cmet.2021.06.012. https://pubmed.ncbi.nlm.nih.gov/34270928/
4. Michot, Caroline, Hubert, Laurence, Brivet, Michèle, de Keyzer, Yves, de Lonlay, Pascale. . LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood. In Human mutation, 31, E1564-73. doi:10.1002/humu.21282. https://pubmed.ncbi.nlm.nih.gov/20583302/
5. Hu, Yunxiang, Han, Jun, Ding, Shengqiang, Liu, Sanmao, Wang, Hong. 2022. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis. In Frontiers in endocrinology, 13, 986384. doi:10.3389/fendo.2022.986384. https://pubmed.ncbi.nlm.nih.gov/36105394/
6. Yang, Chao, Wang, Xu, Wang, Jianying, Yao, Zhongping, Liu, Kai. 2019. Rewiring Neuronal Glycerolipid Metabolism Determines the Extent of Axon Regeneration. In Neuron, 105, 276-292.e5. doi:10.1016/j.neuron.2019.10.009. https://pubmed.ncbi.nlm.nih.gov/31786011/